Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet

Experimental Gerontology

Volumn 45, Issue 3, 2010, Pages 195-201

  Zhuo, Jia Min ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

secretase; Amyloid; APP metabolism; Hyperhomocysteinemia; Tg2576 mice

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; BETA SECRETASE 1; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; NICASTRIN; PRESENILIN 1;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE EXACERBATION; FEMALE; FOLIC ACID DEFICIENCY; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PYRIDOXINE DEFICIENCY; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; HYPERHOMOCYSTEINEMIA; MICE; MICE, TRANSGENIC; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY;

MUS; MUS MUSCULUS;

EID: 76749128435     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.12.005     Document Type: Article

References (51)

1. Bernardo A., McCord M., Troen A.M., Allison J.D., and McDonald M.P. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol. Aging 28 (2007) 1195-1205
2. Boldyrev A.A., and Johnson P. Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. J. Alzheimers Dis. 11 (2007) 219-228
3. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
4. Chan A., and Shea T.B. Folate deprivation increases presenilin expression, gamma-secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S-adenosyl methionine. J. Neurochem. 102 (2007) 753-760
5. Chan A., Paskavitz J., Remington R., Rasmussen S., and Shea T.B. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am. J. Alzheimers Dis. Other Demen. 23 (2008) 571-585
6. Chan A., Tchantchou F., Rogers E.J., and Shea T.B. Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine. J. Neurochem. 110 (2009) 831-836
7. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., and Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276 (2001) 21562-21570
8. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., and Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998) 1449-1455
9. Firuzi O., Zhuo J., Chinnici C.M., Wisniewski T., and Pratico D. 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. FASEB J. 22 (2008) 1169-1178
10. Flicker L., Martins R.N., Thomas J., Acres J., Taddei K., Vasikaran S.D., Norman P., Jamrozik K., and Almeida O.P. B-vitamins reduce plasma levels of beta amyloid. Neurobiol. Aging 29 (2008) 303-305
11. Frederikse P.H., Garland D., Zigler Jr. J.S., and Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J. Biol. Chem. 271 (1996) 10169-10174
12. Fuso A., Seminara L., Cavallaro R.A., D'Anselmi F., and Scarpa S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 28 (2005) 195-204
13. Fuso A., Nicolia V., Cavallaro R.A., Ricceri L., D'Anselmi F., Coluccia P., Calamandrei G., and Scarpa S. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 37 (2008) 731-746
14. Fuso, A., Nicolia, V., Pasqualato, A., Fiorenza, M.T., Cavallaro, R.A., Scarpa, S., 2009. Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol. Aging. [Epub ahead of print].
15. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. 115 (2005) 1121-1129
16. Guenette S.Y. Mechanisms of Abeta clearance and catabolism. Neuromol. Med. 4 (2003) 147-160
17. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran Jr. L.J., Kohl B., Rao V., Kisiel W., Stern D.M., and Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107 (2001) 675-683
18. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
19. Jacobsen D.W. Hyperhomocysteinemia and oxidative stress: time for a reality check?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1182-1184
20. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21 (2001) 372-381
21. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22 (2002) 1752-1762
22. Leblhuber F., Walli J., Artner-Dworzak E., Vrecko K., Widner B., Reibnegger G., and Fuchs D. Hyperhomocysteinemia in dementia. J. Neural. Transm. 107 (2000) 1469-1474
23. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., and Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
24. LeVine III H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309 (1999) 274-284
25. Li H., Lewis A., Brodsky S., Rieger R., Iden C., and Goligorsky M.S. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?. Circulation 105 (2002) 1037-1043
26. Lipton S.A., Kim W.K., Choi Y.B., Kumar S., D'Emilia D.M., Rayudu P.V., Arnelle D.R., and Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 5923-5928
27. Luchsinger J.A., Tang M.X., Miller J., Green R., Mehta P.D., and Mayeux R. Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem. Res. 32 (2007) 775-781
28. Matte C., Mackedanz V., Stefanello F.M., Scherer E.B., Andreazza A.C., Zanotto C., Moro A.M., Garcia S.C., Goncalves C.A., Erdtmann B., Salvador M., and Wyse A.T. Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem. Int. 54 (2009) 7-13
29. Mazur-Kolecka B., Kowal D., Sukontasup T., Dickson D., and Frackowiak J. The effect of oxidative stress on amyloid precursor protein processing in cells engaged in beta-amyloidosis is related to apolipoprotein E genotype. Acta Neuropathol. 108 (2004) 287-294
30. McCaddon A., Davies G., Hudson P., Tandy S., and Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13 (1998) 235-239
31. McCully K.S. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann. Clin. Lab. Sci. 39 (2009) 219-232
32. Morris M.S. Homocysteine and Alzheimer's disease. Lancet Neurol. 2 (2003) 425-428
33. Morris M.C., Evans D.A., Schneider J.A., Tangney C.C., Bienias J.L., and Aggarwal N.T. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J. Alzheimers Dis. 9 (2006) 435-443
34. Osenkowski P., Ye W., Wang R., Wolfe M.S., and Selkoe D.J. Direct and potent regulation of gamma-secretase by its lipid microenvironment. J. Biol. Chem. 283 (2008) 22529-22540
35. Pacheco-Quinto J., Rodriguez de Turco E.B., DeRosa S., Howard A., Cruz-Sanchez F., Sambamurti K., Refolo L., Petanceska S., and Pappolla M.A. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis. 22 (2006) 651-656
36. Pfeiffer C.M., Twite D., Shih J., Holets-McCormack S.R., and Gunter E.W. Method comparison for total plasma homocysteine between the Abbott IMx analyzer and an HPLC assay with internal standardization. Clin. Chem. 45 (1999) 152-153
37. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., and Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21 (2001) 4183-4187
38. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Forloni G., Tettamanti M., and Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80 (2004) 114-122
39. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., and Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82 (2005) 636-643
40. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., and Duff K.E. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8 (2001) 890-899
41. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
42. Song F., Poljak A., Smythe G.A., and Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res. Rev. 61 (2009) 69-80
43. Streck E.L., Delwing D., Tagliari B., Matte C., Wannmacher C.M., Wajner M., and Wyse A.T. Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem. Int. 43 (2003) 597-602
44. Streck E.L., Matte C., Vieira P.S., Calcagnotto T., Wannmacher C.M., Wajner M., and Wyse A.T. Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. Biochim. Biophys. Acta 1637 (2003) 187-192
45. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., and Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 18 (2004) 323-325
46. Sung S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., and Pratico D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165 (2004) 2197-2206
47. The Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015-2022.
48. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., and Selhub J. The atherogenic effect of excess methionine intake. Proc. Natl. Acad. Sci. USA 100 (2003) 15089-15094
49. Troen A.M., Shea-Budgell M., Shukitt-Hale B., Smith D.E., Selhub J., and Rosenberg I.H. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl. Acad. Sci. USA 105 (2008) 12474-12479
50. Vogel T., Dali-Youcef N., Kaltenbach G., and Andres E. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int. J. Clin. Pract. 63 (2009) 1061-1067
51. Zhang C.E., Wei W., Liu Y.H., Peng J.H., Tian Q., Liu G.P., Zhang Y., and Wang J.Z. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174 (2009) 1481-1491